Side-Effects and Complications of Laser Treatment in Diabetic Retinal Disease

被引：40
作者：
Deschler, Emily K. [1 ]
Sun, Jennifer K. [1 ,2 ]
Silva, Paolo S. [1 ,2 ]
机构：
[1] Joslin Diabet Ctr, Beetham Eye Inst, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA
来源：
SEMINARS IN OPHTHALMOLOGY | 2014年 / 29卷 / 5-6期
关键词：
Genetic testing; inherited retinal degeneration; lysosomal disorder; mitochondrial disorder; peroxisomal disorder; primary ciliopathy; syndromic disease; ENDOTHELIAL GROWTH-FACTOR; FOCAL ARGON-LASER; PANRETINAL PHOTOCOAGULATION; CONTRAST SENSITIVITY; PHOTO-COAGULATION; MACULAR EDEMA; SUBRETINAL NEOVASCULARIZATION; PIGMENT EPITHELIUM; VISUAL IMPAIRMENT; DIODE-LASER;
D O I：
10.3109/08820538.2014.959198
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Laser treatment for diabetic retinopathy was the first intraocular treatment to provide a highly effective means for preventing visual loss in patients with diabetes. Although inherently destructive, laser treatment is remarkably effective in preventing visual loss and preserving vision long-term. This review will describe briefly the current techniques and discuss in detail the reported side-effects and potential complications of laser treatment of diabetic retinal disease.
引用
收藏
页码：290 / 300
页数：11
相关论文
共 71 条
  • [1] SYNTHESIS AND SECRETION OF VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR BY HUMAN RETINAL-PIGMENT EPITHELIAL-CELLS
    ADAMIS, AP
    SHIMA, DT
    YEO, KT
    YEO, TK
    BROWN, LF
    BERSE, B
    DAMORE, PA
    FOLKMAN, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 193 (02) : 631 - 638
  • [2] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [3] Diode laser (810 nm) versus argon green (514 nm) modified grid photocoagulation for diffuse diabetic macular edema
    Akduman, L
    Olk, RJ
    [J]. OPHTHALMOLOGY, 1997, 104 (09) : 1433 - 1441
  • [4] American Diabetes Association, 2013, ADAFASTFACTS MARCH 2
  • [5] [Anonymous], 1987, Int Ophthalmol Clin, V27, P254, DOI DOI 10.1097/00004397-198702740-00005
  • [6] DIODE VERSUS ARGON-GREEN LASER PANRETINAL PHOTOCOAGULATION IN PROLIFERATIVE DIABETIC-RETINOPATHY - A RANDOMIZED STUDY IN 44 EYES WITH A LONG FOLLOW-UP TIME
    BANDELLO, F
    BRANCATO, R
    TRABUCCHI, G
    LATTANZIO, R
    MALEGORI, A
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1993, 231 (09) : 491 - 494
  • [7] Bandello F, 2003, Semin Ophthalmol, V18, P251
  • [8] Beetham W P, 1969, Trans Am Ophthalmol Soc, V67, P39
  • [9] BILATERAL SUBRETINAL NEOVASCULARIZATION AFTER FOCAL ARGON-LASER PHOTOCOAGULATION FOR DIABETIC MACULAR EDEMA
    BERGER, AR
    BONIUK, I
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1989, 108 (01) : 88 - 90
  • [10] BIRCH J, 1981, T OPHTHAL SOC UK, V101, P93
12345678